Therefore, patients with DM may exhibit fluctuations in ChT determined by multiple factors, including the length of diabetes, the presence and severity of retinopathy or macular edema, the stage of retinopathy, and the extent of treatment being received. This evidence concerns the gene SLC5A7 and retinal disorder.